BELGRADE, Mont. , Aug. 13, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, is pleased to announce the addition of David Goodman , MD, MSE to the board of

Second Quarter 2014 Revenues Increase Approximately 7.5% Over Second Quarter 2013 BELGRADE, Mont. , Aug. 12, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today reported

BELGRADE, Mont. , Aug. 12, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft materials and bioactive coatings for medical applications, announced today The Spine Journal has published positive results reported on the evaluation

BELGRADE, Mont. , Aug. 6, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced the completion of its previously announced underwritten public offering of 1,143,000

BELGRADE, Mont. , Aug. 5, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE:BONE), a leader in the development of bone graft materials and bioactive coatings for medical applications, announced today that The Journal of Foot & Ankle Surgery has published a study on the "Role of

BELGRADE, Mont. , Aug. 1, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced the pricing of its previously announced underwritten public offering.

BELGRADE, Mont. , July 31, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced that it intends to offer shares of its common stock and warrants to purchase common

BELGRADE, Mont. , July 29, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that it will release its financial results for the period ended June 30,

BELGRADE, Mont. , July 23, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that a 1:10 reverse split of its common stock will be effective at the

Second Quarter total revenue expected to be in the range of $8.75 million to $8.85 million , an increase of approximately 6-7% over the same period last year. BELGRADE, Mont. , July 21, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of